Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.21 USD
Change Today -0.018 / -1.47%
Volume 80.9K
As of 8:10 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

chromadex corp (CDXC) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/6/15 - $1.72
52 Week Low
12/16/14 - $0.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CHROMADEX CORP (CDXC)

Related News

No related news articles were found.

chromadex corp (CDXC) Related Businessweek News

No Related Businessweek News Found

chromadex corp (CDXC) Details

ChromaDex Corporation, a natural products company, through its subsidiaries, discovers, acquires, develops, and commercializes proprietary-based ingredient technologies. It offers bulk raw materials for use in dietary supplements, food, beverages, and cosmetic products; and supplies reference standards, materials, and kits to conduct quality control of raw materials and consumer products, as well as supplies fine chemicals and phytochemicals. The company also provides a range of contract services ranging from routine contract analysis for the production of dietary supplements, cosmetics, foods, and other natural products to elaborate contract research for clients in these industries; and consulting services in the areas of regulatory support, new ingredient or product development, risk management, and litigation support, as well as product regulatory approval and scientific advisory services. Its products and services in development include Nicotinamide riboside, a vitamin found naturally in milk for enhancing cardiovascular health, glucose levels, cognitive function, and anti-aging effects; Pterostilbene and caffeine co-crystal that are ingredients for the formulation of energy products; and Anthocyanins, which are secondary plant metabolites for use as candidates in the pharmaceutical, dietary supplement, and food colorants industries. The company markets and sells its products to the nutritional supplement, food and beverage, animal health, cosmetic, and pharmaceutical industries directly in the United States and Canada; and through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand, and Mexico. ChromaDex Corporation is headquartered in Irvine, California.

67 Employees
Last Reported Date: 03/19/15

chromadex corp (CDXC) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $305.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $249.2K
Chief Operating Officer
Total Annual Compensation: $179.0K
Compensation as of Fiscal Year 2014.

chromadex corp (CDXC) Key Developments

ChromaDex Corp. Announces Exclusive Worldwide License and Supply Agreement for Anthocyanin Rich Suntava(R) Purple Corn

ChromaDex Corp. announced it has entered into an exclusive worldwide license and supply agreement for patent-pending Suntava® Purple Corn. Suntava® Purple Corn is derived from a proprietary non-GMO purple corn hybrid which contains an extraordinarily high level of anthocyanins. Purple corn is rich in antioxidants and has a natural deep purple color due to the high anthocyanin content. It is grown in the USA, and is handled, harvested, and processed using the same modern, efficient methods and equipment as traditional corn crops. ChromaDex plans to develop an extraction process to concentrate the anthocyanins in Suntava® Purple Corn which will be used to produce a highly concentrated anthocyanin ingredient. Like all of its ingredient technologies, ChromaDex will utilize the expertise of a toll manufacturer to produce the commercial ingredient. ChromaDex believes there is a ready market for cost-effective concentrated anthocyanins having application in dietary supplements, sports nutrition, food & beverage and skin care. Purple corn (Zea mays) is botanically the same species as regular table corn. The pigment in purple corn responsible for its vivid color comes from a group of compounds called anthocyanins. Anthocyanins are antioxidants that belong to a class of plant chemicals known as polyphenols, and are responsible for the purple, violet, blue and red colors in many plants, fruits and vegetables.

ChromaDex Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended April 4, 2015

ChromaDex Corporation reported unaudited consolidated earnings results for the first quarter ended April 4, 2015. For the three months ended April 4, 2015, the company reported net sales of $5.3 million, an increase of 71% as compared to $3.1 million for the three months ended March 29, 2014. This increase was largely due to increased sales in its ingredients business segment, led by its NIAGEN branded nicotinamide riboside. The net loss attributable to common stock holders was $1.0 million or $0.01 per share as compared to a net loss of $1.8 million or $0.02 per share for first quarter of 2014. Operating loss was $906,084 against $1,838,765 a year ago.

ChromaDex Corporation to Report Q1, 2015 Results on May 14, 2015

ChromaDex Corporation announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on May 14, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDXC:US $1.21 USD -0.018

CDXC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Eurofins Scientific SE €284.45 EUR +0.90
Sigma-Aldrich Corp $138.88 USD -0.30
View Industry Companies

Industry Analysis


Industry Average

Valuation CDXC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.5x
Price/Book 35.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHROMADEX CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at